Session Details

POH04 Pediatric Dermatology in Diverse Populations and Healthcare Settings

Fri, Jul 17, 7:30 AM - 8:30 AM
Rendezvous Trianon
1 CME Available Power Hour
View Map

DESCRIPTION

Literature suggests race, ethnicity, socioeconomic status, and gender diversity affect care in dermatology and pediatric dermatology. This session will be a case-based discussion of the diagnosis, treatment, and management of pediatric skin disease with a focus on underserved and/or minority populations, to better understand issues of healthcare equity and improve diagnosis and treatment in pediatric dermatology. The intended audience is all dermatologists who encounter pediatric patients, with intent to provide increased exposure to presentation in diverse patients, highlight disparities in access and care, and ultimately to improve healthcare outcomes for vulnerable populations.

LEARNING OBJECTIVES

1.

Recognize and diagnose pediatric skin disease in marginalized populations, including racial, socioeconomic and gender minorities.

2.

Identify considerations for treatment of children and adolescents in resource-limited and community health settings.

3.

Discuss the impact of equity on the management of pediatric skin disease.

SCHEDULE

7:30 AM

Discussion

Anna Cristina Garza-Mayers, MD, PhD, FAAD

7:45 AM

Discussion

Adena Rosenblatt, MD, PhD, FAAD

8:00 AM

Discussion

Sonal D. Shah, MD, FAAD

8:15 AM

Discussion

Sarah Servattalab, MD, FAAD

DIRECTOR

Anna Cristina Garza-Mayers, MD, PhD, FAAD

Anna Cristina Garza-Mayers, MD, PhD, FAAD

Seattle Children's Hospital, University of Washington

SPEAKERS

Adena Rosenblatt, MD, PhD, FAAD

Adena Rosenblatt, MD, PhD, FAAD

Sarah Servattalab, MD, FAAD

Sarah Servattalab, MD, FAAD

Boston Children’s Hospital

Sonal D. Shah, MD, FAAD

Sonal D. Shah, MD, FAAD

University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine

DISCLOSURES

Anna Cristina Garza-Mayers, MD, PhD, FAAD

Incyte – Investigator(No Compensation Received); Sanofi – Investigator(No Compensation Received); Sanofi/Regeneron – Advisory Board(Honoraria);

Adena Rosenblatt, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Sarah Servattalab, MD, FAAD

Cardinal Health – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Investigator(No Compensation Received); True North Insights – Consultant (1099 relationship)(Honoraria);

Sonal D. Shah, MD, FAAD

UpToDate, Inc – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);